Gum disease may alter key hormone and oxidative markers in diabetes patients

NCT ID NCT07691060

First seen Jul 08, 2026 · Last updated Jul 09, 2026 · Updated 1 time

Summary

This observational study investigates how different levels of gum health influence asprosin (a hormone) and total oxidant/antioxidant levels in people with type 2 diabetes. Researchers will collect fluid from around the gums and blood samples from 67 participants to compare these markers between those with healthy gums, gingivitis, and periodontitis. The goal is to better understand the connection between oral health and systemic diabetes-related changes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study could reveal how gum disease influences diabetes-related hormones and oxidative stress, pointing toward better monitoring or treatment strategies.
What could go wrong
This is an observational study, not a treatment trial. It measures associations, not cause and effect, and results may not apply to all people with diabetes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GINGIVAL DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Health Sciences Türkiye, Gülhane Faculty of Dentistry

    Ankara, Ankara, 06100, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.